BIO
Bio-Rad Laboratories, Inc.
NYSE · Healthcare · Medical - Devices · US
$386.11
−0.46%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+31.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | BARRY JAMES · officer: EVP, President, LSG | M-Exempt | 251 | $0.00 |
| Sep 3, 2026 | BARRY JAMES · officer: EVP, President, LSG | M-Exempt | 425 | $0.00 |
| Sep 3, 2026 | Allison Schwartz · director | M-Exempt | 75 | $0.00 |
| Sep 3, 2026 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | F-InKind | 2,336 | $381 |
| Sep 3, 2026 | BARRY JAMES · officer: EVP, President, LSG | M-Exempt | 174 | $0.00 |
| Sep 3, 2026 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | M-Exempt | 2,082 | $0.00 |
| Sep 3, 2026 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | M-Exempt | 5,087 | $0.00 |
| Sep 3, 2026 | Allison Schwartz · director | M-Exempt | 117 | $0.00 |
| Sep 3, 2026 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | M-Exempt | 3,005 | $0.00 |
| Sep 3, 2026 | Allison Schwartz · director | F-InKind | 43 | $381 |
| Sep 3, 2026 | Allison Schwartz · director | M-Exempt | 42 | $0.00 |
| Sep 3, 2026 | BARRY JAMES · officer: EVP, President, LSG | F-InKind | 154 | $381 |
| Jul 28, 2026 | ENGELHARDT EVA ANETTE · officer: EVP, President, CDG | M-Exempt | 246 | $0.00 |
| Jul 28, 2026 | ENGELHARDT EVA ANETTE · officer: EVP, President, CDG | F-InKind | 89 | $314 |
| May 13, 2026 | ENGELHARDT EVA ANETTE · officer: EVP, President, CDG | Sale | 550 | $247 |
| Apr 28, 2026 | Lakkaraju Roop Kalyan · officer: EVP, Chief Financial Officer | F-InKind | 420 | $288 |
| Apr 28, 2026 | Lakkaraju Roop Kalyan · officer: EVP, Chief Financial Officer | M-Exempt | 1,078 | $0.00 |
| Apr 28, 2026 | ENLOE COURTNEY C · officer: EVP, General Counsel & Sec | M-Exempt | 186 | $0.00 |
| Apr 28, 2026 | ENLOE COURTNEY C · officer: EVP, General Counsel & Sec | F-InKind | 77 | $288 |
| Apr 23, 2026 | PEI MELINDA LITHERLAND · director | A-Award | 369 | $0.00 |
| Apr 23, 2026 | EDWARDS JEFFREY L · director | M-Exempt | 407 | $0.00 |
| Apr 23, 2026 | EDWARDS JEFFREY L · director | A-Award | 369 | $0.00 |
| Apr 23, 2026 | Hinckley Greg K · director | A-Award | 369 | $0.00 |
| Apr 23, 2026 | PEI MELINDA LITHERLAND · director | M-Exempt | 407 | $0.00 |
| Apr 23, 2026 | PINKSTON ARNOLD A · director | A-Award | 369 | $0.00 |
| Apr 23, 2026 | PINKSTON ARNOLD A · director | M-Exempt | 407 | $0.00 |
| Apr 23, 2026 | Hinckley Greg K · director | M-Exempt | 407 | $0.00 |
| Nov 10, 2025 | BARRY JAMES · officer: EVP, President, LSG | Sale | 700 | $306 |
| Oct 28, 2025 | DiVincenzo Jonathan P. · officer: President & COO | F-InKind | 950 | $340 |
| Oct 28, 2025 | DiVincenzo Jonathan P. · officer: President & COO | M-Exempt | 1,869 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 121Increased 257Reduced 262Sold out 53
| Filer | Action | Shares | Filed |
|---|---|---|---|
| First Eagle Investment Management, LLC | Increased | 2,606,219 | Aug 24, 2026 |
| FIRST EAGLE INVESTMENT MANAGEMENT, LLC | Increased | 2,602,772 | May 14, 2026 |
| BlackRock, Inc. | Increased | 1,698,929 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 1,680,060 | May 13, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 1,089,323 | May 7, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 944,548 | Aug 11, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 831,165 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 829,186 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 826,972 | Aug 13, 2026 |
| ARIEL INVESTMENTS, LLC | Increased | 816,751 | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 816,198 | Aug 13, 2026 |
| ARIEL INVESTMENTS, LLC | Increased | 785,961 | May 14, 2026 |
| EARNEST PARTNERS LLC | Reduced | 588,731 | May 15, 2026 |
| EARNEST PARTNERS LLC | Reduced | 580,752 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 571,762 | Aug 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026